Diferencia entre revisiones de «CMV esophagitis»

(Prepared the page for translation)
(Marked this version for translation)
 
Línea 2: Línea 2:
<translate>
<translate>


==Background==
==Background== <!--T:1-->


<!--T:2-->
*[[Special:MyLanguage/Cytomegalovirus|Cytomegalovirus]] (CMV) gastrointestinal disease is an uncommon but serious complication of [[Special:MyLanguage/AIDS|AIDS]].
*[[Special:MyLanguage/Cytomegalovirus|Cytomegalovirus]] (CMV) gastrointestinal disease is an uncommon but serious complication of [[Special:MyLanguage/AIDS|AIDS]].
*The diagnosis of CMV gastrointestinal disease should be suspected in patients with CD4 cell counts <50 cells/microL who present with symptoms of esophagitis, gastritis, enteritis, or colitis.
*The diagnosis of CMV gastrointestinal disease should be suspected in patients with CD4 cell counts <50 cells/microL who present with symptoms of esophagitis, gastritis, enteritis, or colitis.
Línea 9: Línea 10:




==Clinical Features==
==Clinical Features== <!--T:3-->


<!--T:4-->
*[[Special:MyLanguage/Odynophagia|Odynophagia]]
*[[Special:MyLanguage/Odynophagia|Odynophagia]]
*[[Special:MyLanguage/Dysphagia|Dysphagia]]
*[[Special:MyLanguage/Dysphagia|Dysphagia]]
Línea 18: Línea 20:




==Differential Diagnosis==
==Differential Diagnosis== <!--T:5-->


</translate>
</translate>
Línea 29: Línea 31:




==Evaluation==
==Evaluation== <!--T:6-->




==Management==
==Management== <!--T:7-->


<!--T:8-->
**[[Special:MyLanguage/Ganciclovir|Ganciclovir]]: 5mg/kg/dose IV q12h
**[[Special:MyLanguage/Ganciclovir|Ganciclovir]]: 5mg/kg/dose IV q12h
**[[Special:MyLanguage/Foscarnet|Foscarnet]]: 60mg/kg/dose q8h or 90mg/kg/dose q12h
**[[Special:MyLanguage/Foscarnet|Foscarnet]]: 60mg/kg/dose q8h or 90mg/kg/dose q12h
Línea 42: Línea 45:




==Disposition==
==Disposition== <!--T:9-->




==See Also==
==See Also== <!--T:10-->


<!--T:11-->
*[[Special:MyLanguage/Cytomegalovirus (CMV) infection|Cytomegalovirus (CMV) infection]]
*[[Special:MyLanguage/Cytomegalovirus (CMV) infection|Cytomegalovirus (CMV) infection]]




==External Links==
==External Links== <!--T:12-->




==References==
==References== <!--T:13-->


<!--T:14-->
<references/>
<references/>


<!--T:15-->
[[Category:ID]] [[Category:GI]]
[[Category:ID]] [[Category:GI]]
</translate>
</translate>

Revisión actual - 12:26 7 ene 2026

Otros idiomas:

Background

  • Cytomegalovirus (CMV) gastrointestinal disease is an uncommon but serious complication of AIDS.
  • The diagnosis of CMV gastrointestinal disease should be suspected in patients with CD4 cell counts <50 cells/microL who present with symptoms of esophagitis, gastritis, enteritis, or colitis.
  • The incidence of CMV gastrointestinal disease has decreased substantially since antiretroviral therapy (ART) became available


Clinical Features


Differential Diagnosis

Esophagitis Types

CMV Diseases


Evaluation

Management

    • Ganciclovir: 5mg/kg/dose IV q12h
    • Foscarnet: 60mg/kg/dose q8h or 90mg/kg/dose q12h
    • Valganciclovir: 900mg PO twice daily
      • May be used for induction therapy, in place of intravenous ganciclovir, in patients who can tolerate and absorb oral medications
    • The recommended duration of therapy for CMV gastrointestinal disease in patients with AIDS is 3-6 weeks
    • Chronic maintenance therapy is not recommended for CMV gastrointestinal disease unless there is concurrent retinitis or recurrent gastrointestinal disease after induction therapy has been discontinued.


Disposition

See Also


External Links

References